Company Number: 14356986

Analysis Date: 2025-07-20 15:19 UTC

Financial Health Assessment of DR CIENTANNI LIMITED

---

1. Financial Health Score: B

Explanation:
The company exhibits a stable financial position with positive net current assets and net assets, indicating a "healthy cash flow" and a solid equity base relative to its size and stage. However, the early stage of the company (just over one year old) and limited financial complexity warrant cautious optimism rather than a top grade. The presence of director loans (debtor balance from a director) is common in startups but should be managed carefully.

---

2. Key Vital Signs

Metric	Value	Interpretation
Current Assets	£4,537	Includes £1,799 cash indicating reasonable liquidity for immediate obligations.
Current Liabilities	£862	Low short-term liabilities relative to assets, suggesting good short-term solvency.
Net Current Assets	£3,675	Positive working capital indicates the company can cover short-term debts comfortably.
Net Assets (Equity)	£3,675	Positive equity indicates the company is "financially solvent" with resources exceeding liabilities.
Cash at Bank	£1,799	Cash buffer is modest but adequate for operational needs at this stage.
Debtors	£2,738	Includes a director loan, repaid post year-end; manageable but should be monitored.
Shareholders’ Funds	£3,675	Equity fully matches net assets, indicating no hidden liabilities.
Corporation Tax Liability	£862	Current tax payable, a normal operating expense.

Additional Notes:

• The company has 2 employees including directors, consistent with a small medical advisory practice.
• No audit requirement due to small company status, which reduces administrative burden.

---

3. Diagnosis: Financial "Health" Narrative

DR CIENTANNI LIMITED is akin to a young patient just starting its "life" in the corporate world. Its financial "vitals" show a stable heart rate with positive net assets and working capital, indicating it can meet immediate obligations without strain. The "symptom" of a director loan appearing in debtors is a typical "supportive intervention" in startups and has been resolved post year-end, reflecting good internal management of funds.

The company's balance sheet is clean, with no long-term liabilities or overdrafts reported, suggesting no chronic distress. The £862 corporation tax creditor is a normal "tax liability symptom" that companies face annually.

Given its small size and early stage, the company is not yet showing signs of financial stress or distress. However, the relatively modest cash reserves imply it should continue cautious financial management to maintain liquidity as it grows.

---

4. Recommendations: Prescriptions for Financial Wellness

• Maintain Strong Cash Flow Monitoring:
  Although current cash levels are adequate, continue to monitor cash flow closely to avoid liquidity "shortness of breath," especially as the business scales or incurs new expenses.

• Manage Director Loans Transparently:
  Director advances should be formalised and repaid promptly to avoid any governance "infections" that might arise from unclear financial arrangements.

• Build Reserves for Growth:
  Aim to increase retained earnings and cash reserves to build a stronger buffer against unforeseen expenses or investment needs—this is akin to "building immune strength" for the business.

• Plan for Tax Payments:
  Set aside funds regularly to cover corporation tax and other liabilities, reducing risk of last-minute financial "fevers."

• Regular Financial Reviews:
  Conduct quarterly financial health checks to detect any emerging "symptoms" early and adjust strategy accordingly.

• Consider Professional Audit as Growth Occurs:
  As the company grows beyond small company thresholds, an audit may become mandatory. Early preparation will ensure smooth transitions and continued financial clarity.

---